Table 2

Operating characteristics of the ACR-1997, SLICC-2012 and EULAR/ACR-2019 classification criteria in the SLE and control cohorts

AUCCut-off valueSensitivitySpecificityAccuracyPPVNPV+LR−LR
ACR-19970.972 (0.957 to 0.983)482.1% (77.7% to 86.0%)96.4% (94.0% to 98.0%)89.6% (87.1% to 91.7%)95.4% (92.5% to 97.2%)85.5% (82.5% to 88.1%)22.578 (13.470 to 37.845)0.186 (0.148 to 0.232)
SLICC-20120.986 (0.975 to 0.993)498.0% (95.9% to 99.2%)92.2% (89.1% to 95.7%)95.0% (93.1% to 96.4%)92.0% (89.1% to 94.2%)98.1% (96.1% to 99.1%)12.578 (8.918 to 17.741)0.022 (0.010 to 0.045)
EULAR/ACR-20190.983 (0.970 to 0.991)1097.4% (95.2% to 98.8%)91.4% (88.2% to 94.0%)94.3% (92.4% to 95.9%)91.2% (88.2% to 93.5%)97.5% (95.4% to 98.7%)11.368 (8.200 to 15.761)0.028 (0.015 to 0.053)
  • ACR, American College of Rheumatology; AUC, area under curve; EULAR, European Alliance of Associations for Rheumatology; −LR, negative likelihood ratio; +LR, positive likelihood ratio; NPV, negative predictive value; PPV, positive predictive value; SLICC, Systemic Lupus International Collaborating Clinics.